PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centro de Biotecnología Acuícola, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.\', \'Department of Biology, Faculty of Chemistry and Biology, University of Santiago de Chile, Santiago, Chile.\', \'Department of Computer Science, University of Concepcion, Concepción, Chile.\', \'Hospital de Urgencia Asistencia Pública (HUAP), Santiago, Chile.\', \'Centro de Nanociencia y Nanotecnología CEDENNA, Universidad de Santiago de Chile, Santiago, Chile.\', \'Facultad de Medicina Veterinaria y Agronomía, Universidad de Las Américas, Santiago, Chile.\', \'Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Bellaterra, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fpubh.2022.797569
?:doi
?:hasPublicationType
?:journal
  • Frontiers in public health
is ?:pmid of
?:pmid
?:pmid
  • 35387187
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.769
?:rankingScore_hIndex
  • 23
?:title
  • Description of Symptoms Caused by the Infection of the SARS-CoV-2 B.1.621 (Mu) Variant in Patients With Complete CoronaVac Vaccination Scheme: First Case Report From Santiago of Chile.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all